Overview: Homocitrulline Levels TestIntroduction: The Homocitrulline Levels Test measures homocitrulline to diagnose metabolic disorders like HHH syndrome, causing developmental delays or neurological issues, aiding in diagnosis. Affecting 1 in 100,000 people, HHH syndrome poses diagnostic challenges due to rare presentation. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses LC-MS/MS for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Homocitrulline Test, HHH Syndrome Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Metabolic testing began in the 1970s with research by Brusilow, who linked homocitrulline to urea cycle disorders. LC-MS/MS advancements in the 2000s by Agilent improved detection, surpassing earlier amino acid analysis.
Purpose: Measures homocitrulline levels to diagnose HHH syndrome, guides dietary or supportive therapy, and evaluates patients with developmental delays, aiming to manage symptoms.
Test Parameters: Homocitrulline levels
Pretest Condition: No special preparation required. Collect plasma or urine. Report history of metabolic issues.
Specimen: Plasma (NaHep, 2-4 mL), Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document developmental delay or neurological issues. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., encephalopathy), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure homocitrulline, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated homocitrulline confirms HHH syndrome, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal levels may require genetic tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Urine amino acid analysis, ammonia levels, or genetic panel to confirm diagnosis.
Test Limitations: Specific to homocitrulline; correlation with symptoms needed. False negatives possible with low levels.
References: ACMG Guidelines, 2023; Journal of Inherited Metabolic Disease, Brusilow SW, 2022.
